Pharmacy News EU

STOCK MARKETING INC PRESENTS : (OTCBB: NPHC) Nutra Pharma Corp., (NASDAQ: GNBT) Generex Biotechnology Corp., (OTCBB: VKNG) Viking Systems, Inc., (OTCBB: ISCO) International Stem Cell Corp., (OTCBB: AJGH) American Jianye Greentech Holdings Inc., (OTCBB: NWCI) Newcardio, Inc.www.StockMarketingInc.comFor More Information email us!! Steve@StockMarketingInc.com
(OTCBB: NPHC – Nutra Pharma Corp.)LATEST NEWS!!Nutra Pharma Receives Patent for Novel Antiviral Treatment [...]

IRVINE, Calif., July 29 /PRNewswire-FirstCall/ Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its new PowerFit? Aortic Extensions. The PowerFit extensions are designed to provide physicians with enhanced visibility under fluoroscopy to facilitate precise device placement [...]

IRVINE, Calif. Medical device maker Endologix Inc. said Thursday it received Food and Drug Administration approval for its PowerFit Aortic Extensions stent.Stents are mesh-wire tubes that are used to prop arteries open after they have been surgically cleared of fatty plaque. The device is used in surgery to repair abdominal aortic aneurysms.Shares of Endologix [...]

ALISO VIEJO, Calif., July 28 /PRNewswire-FirstCall/ Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today reported financial results for the second quarter ended June 30, 2010. Second quarter 2010 net revenue was $28.7 million, a 21 percent increase over the $23.7 million [...]

LA JOLLA, Calif., July 28 The University of California at San Diego issued the following news release:Bioengineers at the University of California, San Diego and GlySens Incorporated have developed an implantable glucose sensor and wireless telemetry system that continuously monitors tissue glucose and transmits the information to an external receiver. The paper, published in [...]

$176 Million of Cash, No Debt Cash Requirements in 2010 Under $5 Million REMOXY NDA Resubmission Still Anticipated Q4 2010 SAN MATEO, Calif., July 28, 2010 (GLOBE NEWSWIRE) Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reported second quarter financial results. Net loss for the quarter ended June 30, 2010 was $0.8 million, or $0.02 per share, [...]

In Letter to Bristol-Myers Squibb CEO Andreotti, Chiang Asks Drug Giant to Step Up and Join the Other Pharmaceutical Companies? in Reducing Drug Prices for California and its AIDS Drug Assistance Program (ADAP) [...]

SAN MATEO, Calif., July 27 /PRNewswire-FirstCall/ NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today important progress in the implementation of its reimbursement strategy for Qutenza (capsaicin) 8% patch. Qutenza is currently available in the United States for the management of neuropathic pain associated with [...]

LAKE FOREST, Calif.(BUSINESS WIRE) InSight Health Services Holdings Corp. (Insight Imaging?) (OTCBB:ISGT) today announced that it had completed the previously announced acquisition of eight imaging centers in the Phoenix, Arizona, El Paso, Texas, and Las [...]

EMERYVILLE, Calif. Onyx Pharmaceuticals Inc. on Monday reported positive clinical trial results for its cancer drug candidate, saying it worked for some multiple myeloma patients who have seen other therapies fail.Onyx tested carfilzomib on 266 patients in the mid-stage clinical trial. Each of the patients had multiple myeloma, a cancer of the blood, and [...]